LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Yen YT, Yang JC, Chang JB, et al. Down-Regulation of miR-194-5p for Predicting Metastasis in Breast Cancer Cells. Int J Mol Sci. 2021;23(1):325.
   PubMed Web of Science ®Google Scholar
• Chen J, Shi P, Zhang J, et al. CircRNA_0044556 diminishes the sensitivity of triple‑negative breast cancer cells to Adriamycin by sponging miR‑145 and regulating NRAS. Mol Med Rep. 2022;25(2):1–12.
   PubMed Web of Science ®Google Scholar
• Fan Y, He S. The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. Cancer Manag Res. 2022;14:1–17.
   PubMed Web of Science ®Google Scholar
• Carneiro TJ, Araújo R, Vojtek M, et al. Impact of the Pd(2)Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model. Int J Mol Sci. 2021;22(19):10775.
   PubMed Web of Science ®Google Scholar
• Magagna I, Gourdin N, Kieffer Y, et al. CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer. Cancers (Basel). 2021;13(23):5878.
   PubMed Web of Science ®Google Scholar
• Cui Y, Huang Y, Wu X, et al. Hypoxia-induced tRNA-derived fragments, novel regulatory factor for doxorubicin resistance in triple-negative breast cancer. J Cell Physiol. 2019;234(6):8740–8751.
   PubMed Web of Science ®Google Scholar
• Walsh EM, Keane MM, Wink DA, et al. Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes. Crit Rev Oncog. 2016;21(5–6):333–351.
   PubMed Web of Science ®Google Scholar
• Pinkney HR, Black MA, Diermeier SD. Single-Cell RNA-Seq Reveals Heterogeneous lncRNA Expression in Xenografted Triple-Negative Breast Cancer Cells. Biology (Basel). 2021;10(10):987.
   PubMed Web of Science ®Google Scholar
• Matossian MD, Burks HE, Bowles A, et al. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast Cancer Res Treat. 2018;169(2):381–390.
   PubMed Web of Science ®Google Scholar
• Gooding AJ, Zhang B, Gunawardane L, et al. The lncRNA BORG facilitates the survival and chemoresistance of triple-negative breast cancers. Oncogene. 2019;38(12):2020–2041.
   PubMed Web of Science ®Google Scholar
• Lan T, Yuan K, Yan X, et al. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Cancer Res. 2019;79(13):3220–3234.
   PubMed Web of Science ®Google Scholar
• Xin H, Yan Z, Cao J. Long non-coding RNA ABHD11-AS1 boosts gastric cancer development by regulating miR-361-3p/PDPK1 signalling. J Biochem. 2020;168(5):465–476.
   PubMed Web of Science ®Google Scholar
• Cui X, Jiang X, Wei C, et al. Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis. Environ Toxicol Pharmacol. 2020;78:103397.
   PubMed Web of Science ®Google Scholar
• Ji W, Diao YL, Qiu YR, et al. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death Dis. 2020;11(1):16.
   PubMed Web of Science ®Google Scholar
• Sun S, Zhou W, Li X, et al. Nuclear Aurora kinase A triggers programmed death-ligand mediated immune suppression by activating MYC transcription in triple-negative breast cancer. Cancer Commun (Lond). 2021;41(9):851–866.
   PubMed Web of Science ®Google Scholar
• Barrett KLB. Cyclin b1 promoter activity and functional cdk1 complex formation in G1 phase of human breast cancer cells. Cell Biol Int. 2002;26(1):19–28.
   PubMed Web of Science ®Google Scholar
• Mafokwane TM, Samie A. Prevalence of chlamydia among HIV positive andHIV negative patients in the Vhembe District as detected by real time PCR from urine samples. BMC Res Notes. 2016;9(1):102.
   PubMedGoogle Scholar
• Lai YF, Xue C, Liao YH, et al. Differential Expression of Toll-Like Receptor Signaling Pathway Is Associated with Microscopic Polyangiitis in Peripheral Blood Neutrophils. Immunol Invest. 2017;46(4):375–384.
   PubMed Web of Science ®Google Scholar
• Moelans CB, Atanesyan L, Savola SP, et al. Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA). Methods Mol Biol. 2018;1708:537–549.
   PubMedGoogle Scholar
• Ruan L, Ge M, Huang X, et al. Assay of Single-Cell Apoptosis by Ensemble and Single-Molecule Fluorescence Methods: annexin-V/Polyethylene Glycol-Functionalized Quantum Dots as Probes. Langmuir. 2018;34(34):10040–10047.
   PubMed Web of Science ®Google Scholar
• Chung S, Kim SH, Seo Y, et al. Quantitative analysis of cell proliferation by a dye dilution assay: application to cell lines and cocultures. Cytometry A. 2017;91(7):704–712.
   PubMed Web of Science ®Google Scholar
• Pijuan J, Barceló C, Moreno DF, et al. In vitro Cell Migration, Invasion, and Adhesion Assays: from Cell Imaging to Data Analysis. Front Cell Dev Biol. 2019;7:107.
   PubMed Web of Science ®Google Scholar
• Anastasiadi Z, Lianos GD, Ignatiadou E, et al. Breast cancer in young women: an overview. Updates Surg. 2017;69(3):313–317.
   PubMed Web of Science ®Google Scholar
• López-Ozuna VM, Hachim IY, Hachim MY, et al. Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis. Endocr Relat Cancer. 2019;26(3):321–337.
   PubMed Web of Science ®Google Scholar
• Park JH, Ahn JH, Kim SB. How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies. ESMO open. 2018;3(Suppl 1):e000357.
   PubMed Web of Science ®Google Scholar
• Li Z, Li Y, Li Y, et al. Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT 1 expression by sponging miR-152. J Biochem Mol Toxicol. 2017;31(9):1–9.
   PubMed Web of Science ®Google Scholar
• Zhou F, Wang J, Chi X, et al. lncRNA TM4SF1-AS1 Activates the PI3K/AKT Signaling Pathway and Promotes the Migration and Invasion of Lung Cancer Cells. Cancer Manag Res. 2020;12:5527–5536.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhuo C, Zhou D, et al. Small Nucleolar RNA Host Gene 1 (SNHG1) and Chromosome 2 Open Reading Frame 48 (C2orf48) as Potential Prognostic Signatures for Liver Cancer by Constructing Regulatory Networks. Med Sci Monit. 2020;26:e920482.
   PubMed Web of Science ®Google Scholar
• Shin TJ, Lee KH, Cho JY. Epigenetic Mechanisms of LncRNAs Binding to Protein in Carcinogenesis. Cancers (Basel). 2020;12(10):2925.
   PubMed Web of Science ®Google Scholar
• Cao H, Wang D, Sun P, et al. RNA-seq reveals microRNA-302b as a suppressor of prostate cancer epithelial-mesenchymal transition by targeting RELA/NF-κB. Am J Cancer Res. 2021;11(11):5715–5725.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang L, Xu X, et al. LncRNA HLA Complex Group 11 Knockdown Alleviates Cisplatin Resistance in Gastric Cancer by Targeting the miR-144-3p/UBE2D1 Axis. Cancer Manag Res. 2021;13:7543–7557.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhou H, Liu J, et al. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells. Biomed Res Int. 2019;2019:5437531.
   PubMed Web of Science ®Google Scholar
• Zhang JF, Liu DH, Deng GM, et al. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p. Bioengineered. 2021;12(2):12070–12086.
   PubMed Web of Science ®Google Scholar
• Li L, Li Q. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T). Bioengineered. 2021;12(2):12394–12406.
   PubMed Web of Science ®Google Scholar